An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer

Míreanna comhchosúla

• An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer.
  de réir: Brady, J, et al.
  Foilsithe / Cruthaithe: (2013)
• A phase I study of pazopanib in combination with FOLFOX 6 or capeOx in subjects with colorectal cancer
  de réir: Brady, J, et al.
  Foilsithe / Cruthaithe: (2009)
• CapeOX as neoadjuvant chemotherapy for locally advanced rectal cancer: might less be more?
  de réir: Tianan Guo, et al.
  Foilsithe / Cruthaithe: (2024-10-01)
• Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
  de réir: Zuo Fei, et al.
  Foilsithe / Cruthaithe: (2019-04-01)
• Case Report: Primary small bowel adenocarcinoma with peritoneal metastasis responded well to a CapeOX + bevacizumab regimen
  de réir: Guang Fu, et al.
  Foilsithe / Cruthaithe: (2023-08-01)